CardioDx Lands $5,000,000 Series D Funding Round

  • Feed Type
  • Date
    5/14/2010
  • Company Name
    CardioDx
  • Mailing Address
    2500 Faber Place Palo Alto, CA 94303
  • Company Description
    Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
  • Website
    http://www.cardiodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    GE Healthymagination Fund